相关实验视频
Updated: Jan 13, 2026

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
756
USP1通过CDC25A二氧化来调节食道癌的进展,以调节CDK1的表达
Jian Feng1,2, Zhiwei Yan1, Jinfeng Ge1
1Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006 Jiangsu Province China.
3 Biotech
|January 8, 2026
概括
该USP1/CDC25A/CDK1通路驱动食道癌症的进展. USP1稳定了CDC25A,促进了细胞增殖和瘤生长,而它的抑制减缓了瘤的发展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 细胞分裂周期25A (CDC25A) 对于细胞周期调节至关重要.
- 对于CDC25A在食道癌症中的作用尚不清楚.
研究的目的:
- 为了研究CDD25A在食道癌中的表达和功能.
- 在食道癌的进展中识别CDC25A的调节机制.
主要方法:
- 使用TCGA数据库,西部斑块,免疫组织化学和RT-qPCR来分析CDC25A表达.
- 进行了细胞增殖,迁移,入侵和亡测试.
- 选了deubiquitinating酶,并确定了USP1.1.
- 在裸体小鼠中进行异种移植瘤生长实验.
主要成果:
- 在食道癌组织中,CDC25A的表达很高.
- 击败CDC25A抑制了扩散,迁移,入侵,并促进了亡.
- 在USP1的作用下,它能使CDC25A脱和稳定.
- 疾病预防控制中心25A针对CDK1以促进扩散.
- 抑制USP1抑制了瘤的生长;CDK1过度表达促进了瘤的生长.
结论:
- USP1/CDC25A/CDK1轴是食道致癌和进展的关键驱动因素.
- 针对这一轴可能为食道癌提供治疗策略.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K

